Navigation Links
irisnote Announces Successful Conclusion of Beta Test Phase
Date:4/3/2013

Redwood City, CA (PRWEB) April 03, 2013

irisnote today announced the successful conclusion of its beta test, which included over 2000 scientists and researchers in corporate, government and academic institutions. irisnote Cloud Edition, an online cloud-based Electronic Laboratory Notebook and intellectual property (IP) management service accelerates research by enabling scientists to document their work, collaborate with others, and ensure their IP is protected.

“At irisnote, we’re building a solution that allows researchers to enter their work where they want in the way they feel most comfortable. Every day research organizations come to us because current methods of maintaining valuable research are inadequate for the job,” said Peter Herz, CEO of irisnote. “irisnote enables scientists to quickly and easily document, manage and review their research. For example, with our new iPad app, notebook entries are totally free-form – users can type text, handwrite with character recognition, dictate, add files of any kind, edit entries, and then flip through their notebooks using intuitive gestures, just like they do when reading eBooks.”

irisnote is built upon a powerful 21 CFR Part 11 compliant ELN engine, ensuring the safety and security of user data. At the same time, irisnote allows users to easily share their work with their colleagues and peers, search for new colleagues with irisnote’s proprietary Find Experts feature, and collaborate in real time through our built-in, compliant messaging platform.

“irisnote’s new offerings provide a platform for the advancement of Scientific Resource Planning. Our new ELN offering is the core of the platform. Institutions the world over are finding that their most valuable asset – their research – is not well managed, protected or controlled,” said Craig Harper, CTO for irisnote. “Now there’s no longer a need for them to use ad-hoc, home-grown solutions that fail t
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015  Eli Lilly and Company (NYSE: LLY ... cancer therapies, reflecting Lilly,s diverse oncology pipeline, during the ... held April 18-22 in Philadelphia , ... is the theme of this year,s AACR meeting and ... its portfolio of therapies that accelerate the pace and ...
(Date:4/20/2015)... Sinovac Biotech Ltd. (Nasdaq: SVA), a leading ... unaudited financial results for the fourth quarter and full ... 2014 Financial Highlights(Compared to the fourth quarter 2013) ... of 11.4% from $22.9 million in the prior year ... pandemic influenza vaccine of $0.1 million in the fourth ...
(Date:4/18/2015)... PHILADELPHIA , April 18, 2015 ... (NASDAQ: CRIS ) will be presenting data ... the American Associate of Cancer Research Annual Meeting ... ).      (Logo: http://photos.prnewswire.com/prnh/20130418/608115 ) ... its proprietary Nicotinamide phosphoribosyltransferase (NAMPT) small molecule inhibitors ...
(Date:4/17/2015)... 17, 2015 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD; ... that develops and commercializes proprietary technologies and products ... it has received approval from the TSX Venture ... common share purchase warrants ("the Warrants") of the ... Company,s May 2013 private placement financing. ...
Breaking Biology Technology:Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 2Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 3Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 4Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 5Lilly Releases Early-Stage Pipeline Data at AACR Annual Meeting 2015 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 2Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 3Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 4Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 5Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 6Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 7Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 8Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 9Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 10Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 11Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 12Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 13Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 14Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 15Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 16Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 17Sinovac Reports Unaudited Fourth Quarter and Full Year 2014 Financial Results 18Aurigene to Present its NAMPT and IRAK-4 Inhibitors Programs at AACR 2015 2SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3
... CryoLife, Inc., (NYSE: CRY ) ... today announced,that it has received 510(k) clearance ... its CryoValve(R) SG pulmonary human heart valve ... proprietary,SynerGraft technology is designed to remove allogeneic ...
... Mass., Feb. 7 Logical Therapeutics, Inc., a,biotechnology ... treat,diseases associated with poorly controlled inflammation, announced today,that ... was presented with the,Distinguished Investigator Award from the ... Critical Care Congress of the Society of Critical,Care ...
... (Nasdaq:,MITI), a biopharmaceutical company developing novel, proprietary antibodies,for ... today,announced that Dr. Christian Itin, President and Chief ... investor conferences; one sponsored,by the Biotechnology Industry Organization ... Dr. Itin will present at the 2008 BIO ...
Cached Biology Technology:CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 2CryoLife Receives FDA 510(k) Clearance for SynerGraft(R) Processed Human Pulmonary Heart Valves 3Logical Therapeutics Co-Founder and CEO Honored with a Distinguished Investigator Award from the American College of Critical Care Medicine 2Micromet to Present at Two Upcoming Investor Conferences 2
(Date:3/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) ... Recognition Market 2015-2019" report to their offering. ... to grow at a CAGR of 23.5 percent over ... present scenario and the growth prospects of the Global ... the market size, the report considers the revenue generated ...
(Date:3/24/2015)... , March 24, 2015   Crossmatch ™, ... today announced that its U.are.U ® 4500 ... Goorin Bros . to achieve PCI compliance ... secures access to the POS terminal, protecting the ... of data breaches. With one-third ...
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... NEW YORK (APRIL 15, 2008) A comprehensive book of ... was released today by the Wildlife Conservation Society. ... on such issues as diseases shared by animals and people; ... as Afghanistan. State of the Wild: A Global Portrait ...
... research demonstrates that novel probe technology based ... force microscopy (AFM) cantilevers for applications such ... and single molecule mechanics measurements. In ... these novel probes simultaneously measure material properties ...
... with high cholesterol in their early 40s are more ... cholesterol, according to research that will be presented at ... Meeting in Chicago, April 1219, 2008. "Our findings ... patients to attack high cholesterol levels in their,40s to ...
Cached Biology News:Wildlife Conservation Society releases definitive 'state of the wild' 2Fast AFM probes measure multiple properties of biomolecules or materials simultaneously 2Fast AFM probes measure multiple properties of biomolecules or materials simultaneously 3